Share on StockTwits

Uniqure BV’s (NASDAQ:QURE) lock-up period is set to expire on Monday, August 4th. Uniqure BV had issued 5,400,000 shares in its public offering on February 5th, American Banking and Market News reports. The total size of the offering was $91,800,000 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Shares of Uniqure BV (NASDAQ:QURE) traded down 2.54% on Friday, hitting $9.96. 19,881 shares of the company’s stock traded hands. Uniqure BV has a one year low of $8.29 and a one year high of $18.75. The stock’s 50-day moving average is $11.94 and its 200-day moving average is $12.63. The company’s market cap is $175.2 million.

Uniqure BV (NASDAQ:QURE) last issued its quarterly earnings data on Friday, June 6th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.07. On average, analysts predict that Uniqure BV will post $-2.25 earnings per share for the current fiscal year.

Uniqure BV is a pharmaceutical company based in the Netherlands. It is primarily engaged in the field of gene therapy for orphan diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.